BCHE and Alzheimer disease: The current drugs for AD, including four cholinesterase inhibitors and one N-methyl-D-aspartate (NMDA) receptor antagonist, have been able to mitigate AD symptoms but cannot cure the disease (Iraji et al., 2020).